Delivery Order SPE2DR25D3103-SPE2DR26F9Y33
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $1,954.08 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, with a performance period through May 1, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Cyclosporine 0.05% eye emulsion medication. The contract has a potential value of $1,954.08 and a performance period through February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for Cyclosporine 0.05% Eye Emulsion (30 units) with a ceiling value of $1,835.52. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing indefinite delivery contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of January 14, 2026. This...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $8,357.70 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of Cyclosporine 0.05% Eye Emulsion, a specialty pharmaceutical product. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide CYCLOSPORINE 0.05% EYE EMULS 60S, a pharmaceutical product. The delivery order has a potential value of $1,979.82 and a completion date of February 20, 2024. AmerisourceBergen Drug Corp, located in Conshohocken, Pennsylvania, is the prime contractor and does not have any major subcontractors listed. This...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,432.00 contract is for the supply of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $10,182.17, is a firm fixed price delivery order for the supply of Cyclosporine 0.05% Eye Emulsion. The award has a completion date of March 27, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as a prime contractor providing...
- The Defense Logistics Agency awarded a $8,041.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (60 count). This is a non-set-aside competitive award with an ultimate completion date of September 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in Conshohocken, PA. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-unit quantities. This $2,744.57 firm fixed-price delivery order is scheduled for completion by October 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen Drug Corp's demonstrated...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order with a ceiling value of $1,082.76 and a performance period through March 19, 2024. The contract does not have a set-aside designation....
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9Y33Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,469.83 to AmerisourceBergen Drug Corp for the supply of Cyclosporine 0.05% eye emulsion (30-count units), with an ultimate completion date of January 20, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. This comprehensive pharmaceutical supply vehicle enables the company to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement serving military and veteran healthcare systems. The company's extensive federal contracting portfolio demonstrates its capability to supply diverse pharmaceutical products across multiple therapeutic domains through open competition. As a prime vendor under the DLA's pharmaceutical supply chain, AmerisourceBergen fulfills ongoing medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning it as a key participant in military medical logistics operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 1/15/26 |